Following President-elect Donald Trump’s decision on Thursday to name Robert F. Kennedy Jr. as head of the Department of Health and Human Services (HHS), stocks for multiple vaccine manufacturing companies dropped during Friday morning’s trading period.
Shares of Pfizer on Friday dropped by 4 percent, while Moderna’s dropped by around 7 percent. Both pharmaceutical companies manufacture commonly used vaccines, including mRNA-based shots for COVID-19. Novavax shares dropped by about 1.6 percent in the same period.
